2025-09-04 - Analysis Report
Okay, here's a report analyzing Intuitive Surgical Inc. (ISRG), incorporating the data you provided.

## Intuitive Surgical Inc. (ISRG) Analysis

**Company Overview:** Intuitive Surgical Inc. designs, manufactures, and markets robotic surgical systems and related instruments.

### 1. Performance vs. S&P 500 (VOO)

*   **ISRG Cumulative Return:** 98.38%
*   **VOO Cumulative Return:** 99.17%
*   **Relative Divergence:** -0.8
    *   **Max Divergence:** 127.7
    *   **Min Divergence:** -6.8
    *   **Relative Divergence Position:** 4.5

**Analysis:** ISRG's cumulative return is slightly lagging behind the S&P 500 (VOO). The relative divergence is currently at -0.8, with a relative divergence position of 4.5, indicating that ISRG's performance is near the bottom of its historical range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha | Beta | Cap(B) |
|------------|--------|--------|-------|------|--------|
| 2015-2017  | 68.0%  | 56.5%  | 39.0% | 0.0  | 43.7   |
| 2016-2018  | 77.0%  | 63.4%  | 59.0% | 0.0  | 57.3   |
| 2017-2019  | 81.0%  | 63.4%  | 52.0% | 0.3  | 70.8   |
| 2018-2020  | 47.0%  | 63.4%  | 28.0% | 0.2  | 97.9   |
| 2019-2021  | 91.0%  | 63.0%  | 43.0% | 0.2  | 129.0  |
| 2020-2022  | -3.0%  | 69.9%  | -6.0% | 0.2  | 95.3   |
| 2021-2023  | -5.0%  | 72.9%  | -23.0% | 0.9  | 121.2  |
| 2022-2024  | 26.0%  | 72.9%  | 0.0%  | 0.9  | 187.4  |
| 2023-2025  | 19.0%  | 72.9%  | -32.0% | 0.7  | 161.3  |

**Analysis:**

*   **CAGR:** Shows strong growth in earlier periods (2015-2021), with recent periods (2021-2025) showing mixed performance.
*   **MDD:** High Maximum Drawdown values across all periods indicate significant volatility.
*   **Alpha:** Generally positive alpha in earlier periods, suggesting outperformance relative to its risk. Negative alpha in recent periods (2020-2025) indicates underperformance.
*   **Beta:** Beta values are generally low, indicating that the stock is less sensitive to market movements.
*   **Cap(B):** The market capitalization has grown significantly over the years.

### 2. Recent Price Action

*   **Current Price:** 449.12
*   **Last Market Data:** Price = 449.82, Previous Close = 469.07, Change = -4.1
*   **5-day Moving Average:** 468.33
*   **20-day Moving Average:** 473.89
*   **60-day Moving Average:** 502.32

**Analysis:** The current price is below all three moving averages (5, 20, and 60-day), suggesting a short-term downtrend. The last market data shows a significant negative change, indicating recent selling pressure.

### 3. Technical Indicators and Expectations

*   **Market Risk Indicator (MRI):** 0.34 (Low Risk)
*   **RSI:** 31.33 (Approaching Oversold)
*   **PPO:** -0.07
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (8 shares - Safe - MRI:0.33)
*   **Delta Previous Relative Divergence (20-day):** -5.8 (Negative - Short-term Decline)
*   **Expected Return:** 947.1% (Long-term, vs. S&P 500)

**Analysis:**

*   The MRI indicates a low-risk environment.
*   The RSI is approaching oversold territory, which could signal a potential bounce.
*   The PPO is negative, confirming the downtrend.
*   The hybrid signal suggests buying 90% of cash.
*   The negative change in relative divergence indicates recent underperformance compared to the S&P 500.
*   A very high expected return suggests significant potential for long-term outperformance, but this should be viewed with caution.
*   The significant negative change (-4.1) in the last market data confirms short-term downward momentum.

### 4. Recent News & Significant Events

*   **Volatility:** Recent volatility influenced by news, earnings, or executive actions.
*   **Analyst Discussions:** Analysts are discussing recent performance in the context of industry trends and global economic factors.
*   **Market Expert Advice:** Monitor recent news and company announcements for risks and opportunities.
*   **Business Developments:** Recent major business developments, regulatory changes, or market events are impacting ISRG.

**Analysis:** The news indicates that ISRG is experiencing notable volatility and is subject to significant market scrutiny. Investors should closely monitor news and announcements for potential impacts.

### 5. Recent Earnings Analysis

| 날짜         | EPS  | 매출      |
|--------------|------|-----------|
| 2025-07-23   | 1.84 | 2.44 B$   |
| 2025-04-23   | 1.95 | 2.25 B$   |
| 2024-10-18   | 1.59 | 2.04 B$   |
| 2024-07-19   | 1.48 | 2.01 B$   |
| 2025-07-23   | 1.48 | 2.01 B$   |

**Analysis:**

*   The most recent EPS (1.84) is strong, but slightly lower than the previous quarter (1.95).
*   Revenue has been increasing over the past few quarters.
*   There appears to be duplicate entry in table ('2025-07-23'), which needs to be verified.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-06-30   | $2.44B    | 66.31%        |
| 2025-03-31   | $2.25B    | 64.69%        |
| 2024-12-31   | $2.41B    | 68.04%        |
| 2024-09-30   | $2.04B    | 67.41%        |
| 2024-06-30   | $2.01B    | 68.30%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE     |
|--------------|------------|---------|
| 2025-06-30   | $17.85B   | 3.69%   |
| 2025-03-31   | $17.11B   | 4.08%   |
| 2024-12-31   | $16.43B   | 4.17%   |
| 2024-09-30   | $15.58B   | 3.63%   |
| 2024-06-30   | $14.71B   | 3.58%   |

**Analysis:**

*   **Revenue:** Shows a general increasing trend over the past year.
*   **Profit Margin:** Remains consistently high, indicating strong operational efficiency.
*   **Equity:** Continues to grow, reflecting increased shareholder value.
*   **ROE:** Fluctuates slightly but remains at a healthy level.

### 7. Overall Analysis

ISRG is a leading company in the robotic surgery market, with strong revenue growth and high profit margins. However, recent stock performance has been lagging the S&P 500, and there is short-term downward momentum. The MRI suggests a low-risk environment, and the RSI indicates the stock is approaching oversold territory, which could present a buying opportunity for long-term investors. The high expected return suggests significant long-term potential, but this should be weighed against the recent volatility and underperformance. The recent news indicates increased market scrutiny. In summary, ISRG presents a mixed picture, with strong fundamentals but recent price weakness. Investors should carefully monitor news, earnings, and technical indicators to make informed decisions.
